TOUJEO

insulin glargine · Sanofi-Aventis U.S. LLC

Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for TOUJEO, covering 2014-12-03 to 2026-03-05. Get the full timeline:

Most recent: EMA Authorised: Toujeo (previously Optisulin) (insulin glargine) — Sanofi-aventis Deutschland GmbH